Información de la revista
Editorial
Problem with radioisotope production: nightmare or good opportunity?
Ignasi Carrió, José Mª Freire
Rev Esp Med Nucl Imagen Mol. 2022;41:137
Original articles
Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning — A retrospective analysis
Bernhard Nilica, Anna Svirydenka, Josef Fritz, Steffen Bayerschmidt, Alexander Kroiss, Leonhard Gruber, Irene Johanna Virgolini
Rev Esp Med Nucl Imagen Mol. 2022;41:138-45
Correlation between brain glucose metabolism (18F-FDG) and cerebral blood flow with amyloid tracers (18F-Florbetapir) in clinical routine: Preliminary evidences
Domenico Albano, Enrico Premi, Alessia Peli, Luca Camoni, Francesco Bertagna, Rosanna Turrone, Barbara Borroni, Vince D. Calhoun, ... Barbara Paghera
Rev Esp Med Nucl Imagen Mol. 2022;41:146-52
Increasing the confidence of 18F-Florbetaben PET interpretations: Machine learning quantitative approximation
Ana María García Vicente, María Jesús Tello Galán, Francisco José Pena Pardo, Mariano Amo-Salas, Beatriz Mondejar Marín, Santiago Navarro Muñoz, Ignacio Rueda Medina, Víctor Manuel Poblete García, ... Ángel Soriano Castrejón
Rev Esp Med Nucl Imagen Mol. 2022;41:153-63
Baseline 18F-FDG PET/CT quantitative parameters as prognostic factors in esophageal squamous cell cancer
A. Martínez, J.R. Infante, J. Quirós, J.I. Rayo, J. Serrano, M. Moreno, P. Jiménez, A. Cobo, A. Baena
Rev Esp Med Nucl Imagen Mol. 2022;41:164-70
Predictive value of 18F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy
Tuğba Başoğlu, Salih Özgüven, Hülya Şahin Özkan, Merve Çınar, Osman Köstek, Nazım Can Demircan, Rukiye Arıkan, Tuğba Akın Telli, ... Perran Fulden Yumuk
Rev Esp Med Nucl Imagen Mol. 2022;41:171-8
Special collaboration
Interventional nuclear medicine's contribution to molecularly targeted precision surgery
R. Valdés Olmos, S. Vidal-Sicart, S. Fuertes Cabero, E. Goñi Gironés, P. Paredes
Rev Esp Med Nucl Imagen Mol. 2022;41:179-87
Interesting images
[18F]FDG PET/CT in an azygos vein spindle-cell sarcoma in a patient with thoracic pain
I. León-Asuero-Moreno, P. Fernández-Rodríguez, J.M. Masero Carretero, Y. Herrera Martínez, J.M. Jiménez-Hoyuela García, I. Acevedo Báñez
Rev Esp Med Nucl Imagen Mol. 2022;41:188-9
Early diagnosis of cardiac sarcoidosis in inflammatory stage on cardiac [18F]FDG PET/MRI. A case report
R. Olivero, J.R. Garcia, P. Bassa, P. Garcia, E. Riera, A. Maceira
Rev Esp Med Nucl Imagen Mol. 2022;41:190-1
Visualizations of metastatic ovarian carcinoma on a bone scintigraphy and SPECT/CT
M. Pudis, J.J. Martín-Marcuartu, A. Feu-Llauradó, J.G. Reyes-Junca, C. Soldevila-Lozano, M. Cortés-Romera
Rev Esp Med Nucl Imagen Mol. 2022;41:192-3
[18F]FDG in chronic infection of complicated aortic endoprosthesis
J. Sabater Sancho, J. Orozco Cortés, T. Mut Dólera, Á. Badenes Romero, E. Casula, B. Cueto Cañadas
Rev Esp Med Nucl Imagen Mol. 2022;41:194-6
Findings of congestive heart failure associated with sunitinib cardiotoxicity in 18F-FDG PET/CT
Cihan Gündoğan, Özge Erol, Ediz Beyhan, Rıza Umar Gürsu, Tevfik Fikret Çermik
Rev Esp Med Nucl Imagen Mol. 2022;41:197-8
FDG PET/CT findings of a child with extramedullary relapsed ALL after allogeneic bone marrow transplantation
Nilufer Yildirim, Dilek Kacar
Rev Esp Med Nucl Imagen Mol. 2022;41:199-200
Letter to the editor
Possible role of 99mTC-Sestamibi scintigraphy in the follow-up of Kawasaki-like disease related to SARS-CoV-2
Nicoletta Urbano, Manuel Scimeca, Rita Bonfiglio, Elena Bonanno, Orazio Schillaci
Rev Esp Med Nucl Imagen Mol. 2022;41:201
Continuing education
Clinical application of [18F]FDG PET/CT in follicular lymphoma
A. Díaz-Silván, L.F. Otón-Sánchez, A.P. Caresia-Aróztegui, M. del Puig Cózar-Santiago, J. Orcajo-Rincón, M. de Arcocha-Torres, R.C. Delgado-Bolton, D. Cabello-García
Rev Esp Med Nucl Imagen Mol. 2022;41:202-12